Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 13;21(2):1669-1678.
doi: 10.1007/s40200-022-01118-9. eCollection 2022 Dec.

Prevalence and reasons influenced medication non-adherence among diabetes patients: A mixed-method study

Affiliations

Prevalence and reasons influenced medication non-adherence among diabetes patients: A mixed-method study

Nor Fadhilah Abdullah et al. J Diabetes Metab Disord. .

Abstract

Objectives: This study aimed to identify the prevalence of medication non-adherence (MNA) and to explore the reasons that influenced MNA among diabetes patients.

Design: This study used the explanatory mixed-method design. Phase one comprised of a cross-sectional study followed by phase two of a qualitative study.

Setting: This study took place at two public hospitals in the Klang Valley, Malaysia.

Participants: About 427 diabetes patients were recruited and 399 of them completed the study. The inclusion criteria were those with age more than 18 years and above, Malaysian citizen, able to understand Malay or English, and were diagnosed with diabetes mellitus for more than one year. The exclusion criteria were those with an intellectual disability and pregnant women. Phase two involved 12 participants recruited from non-adherent patients in phase one of the study.

Results: About 46.6% of the patients failed to adhere to the medication. Malays (OR: 1.66, 95%CI: 1.09 to 2.51, p = 0.017), single/widow or divorced (OR: 1.79, 95%CI: 1.05 to 3.05, p = 0.031) and poor HbA1c (OR: 2.57, 95% CI: 1.61 to 4.10, p = < 0.01) were associated with medication non-adherence. Five main categories emerged as the reasons for medication non-adherence, including perceived benefit of Complementary and Alternative medicine, attitude towards drawback of western medication, poor healthcare providers and patients' relationship, undesirable emotional response towards medication intake, as well as restraints in daily routine and cognitive function.

Conclusions: There are many reasons for patients' non-adherence to their anti-diabetes medication. These findings are important in identifying the factors that influenced non-adherence to recommend reliable patient-centred care strategies in improving medication non-adherence among patients with diabetes.

Keywords: Diabetes mellitus; Medication non-adherence; Mixed-methods study; Reasons.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestOn behalf of all authors, the corresponding author states that there is no conflict of interest.

Similar articles

Cited by

References

    1. Khotkar KK, Chaudhari S, Jadhav PR, Deshmukh YA. Assessment of Medication Adherence in Type II Diabetic Patients: A Cross-sectional Study. MGM J Med Sci. 2017;4(2):65–69. doi: 10.5005/jp-journals-10036-1142. - DOI
    1. Lee CS, Tan JHM, Sankari U, et al. Assessing Oral Medication Adherence among Patients with Type 2 Diabetes Mellitus Treated with Polytherapy in a Developed Asian Community: A Cross-sectional Study. BMJ Open. 2017;7(9):e016317. 10.1136/bmjopen-2017-016317. - PMC - PubMed
    1. Shams N, Amjad S, Kumar N, Ahmed W, Saleem F. Drug non-adherence in type 2 diabetes mellitus: Predictors and associations. J Ayub Med Coll Abbotabad. 2016;28(2):302–307. - PubMed
    1. Curkendall SM, Thomas N, Bell KF, Juneau PL, Weiss AJ. Predictors of medication adherence in patients with type 2 diabetes mellitus. Curr Med Res Opin. 2013;29(10):1275–1286. doi: 10.1185/03007995.2013.821056. - DOI - PubMed
    1. Aghoja O, Avwenaghagha H, Ogba E. Medication adherence and its correlates among diabetic patients in central hospital, Warri, Nigeria. IOSR J Pharm. 2016;6(7 Version 3 (July 2016)):96–103.

LinkOut - more resources